RedHill Biopharma (RDHL) Income from Continuing Operations (2012 - 2023)
RedHill Biopharma (RDHL) posted Income from Continuing Operations of -$8.08 million for the year ended Dec 31, 2025, compared with $360,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Income from Continuing Operations (2012 - 2023) Analysis & Trends
Since the year ended Dec 31, 2009, RedHill Biopharma has reported Income from Continuing Operations for 17 years.
- Annual Income from Continuing Operations has run from a low of -$97.74 million in the year ended Dec 31, 2021 to a high of $360,000 in the year ended Dec 31, 2024 over five years.
- Business Quant data shows RDHL's Income from Continuing Operations at $360,000 in the year ended Dec 31, 2024, -$18.5 million in the year ended Dec 31, 2023, -$71.67 million in the year ended Dec 31, 2022 and -$97.74 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 58.92 Mn |
| Mar 31, 2023 | -7.92 Mn |
| Dec 31, 2022 | -69.52 Mn |
| Sep 30, 2022 | -21.49 Mn |
| Jun 30, 2022 | 6.61 Mn |
| Mar 31, 2022 | 12.73 Mn |
| Dec 31, 2021 | -145.25 Mn |
| Sep 30, 2021 | 13.41 Mn |
| Jun 30, 2021 | 20.65 Mn |
| Mar 31, 2021 | 13.44 Mn |
| Dec 31, 2020 | 15.09 Mn |
| Sep 30, 2020 | 10.28 Mn |
| Jun 30, 2020 | 8.95 Mn |
| Mar 31, 2020 | 16.45 Mn |
| Dec 31, 2019 | 11.84 Mn |
| Sep 30, 2019 | 9.85 Mn |
| Jun 30, 2019 | 13.85 Mn |
| Mar 31, 2019 | 8.56 Mn |
| Dec 31, 2018 | 12.40 Mn |
| Sep 30, 2018 | 9.39 Mn |
API Access
RedHill Biopharma Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();